Glazer Capital LLC’s Boston Scientific BSX Stock Holding History

Glazer Capital LLC’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$768K	Buy	+17,999	New	+$977K	0.02%	294

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Glazer Capital LLC's BSX Position: Q2 2026 in Review

Glazer Capital LLC opened a new position in Boston Scientific (BSX) in Q2 2026: 17,999 shares worth $768K. The stake represents 0.02% of the portfolio and ranks #294 among its holdings.

1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Glazer Capital LLC held 17,999 shares of Boston Scientific worth $768K as of Q2 2026.
Boston Scientific was a new Glazer Capital LLC position in Q2 2026.
Boston Scientific made up 0.02% of Glazer Capital LLC's portfolio in Q2 2026, its #294 holding.
1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Glazer Capital LLC's 13F filing for Q2 2026, filed 17 Aug 2026.